Opportunistic Intracellular Bacteria and Immunity INFECTIOUS AGENTS AND PATHOGENESIS SeriesEditors: Mauro Bendinelli, Universityof Pisa Herman Friedman, University ofSouthFlorida College ofMedicine Recent volumes in the series: DNATUMOR VIRUSES Oncogenic Mechanisms Edited by Giuseppe Barbanti-Brodano,Mauro Bendinelli, and Herman Friedman ENTERIC INFECTIONS AND IMMUNITY Edited by Lois J. Paradise, Mauro Bendinelli, and Herman Friedman FUNGAL INFECTIONS AND IMMUNE RESPONSES Edited by Juneann W. Murphy, Herman Friedman, and Mauro Bendinelli HERPESVIRUSESAND IMMUNITY Edited by Peter G. Medveczky, Herman Friedman, and Mauro Bendinelli MICROORGANISMSAND AUTOIMMUNE DISEASES Edited by Herman Friedman, Noel R. Rose, and Mauro Bendinelli NEUROPATHOGENIC VIRUSES AND IMMUNITY Edited by Steven Specter, Mauro Bendinelli, and Herman Friedman OPPORTUNISTIC INTRACELLULAR BACTERIA AND IMMUNITY Edited by Lois J. Paradise, Herman Friedman, and Mauro Bendinelli PSEUDOMONAS AERUGINOSA AS AN OPPORTUNISTIC PATHOGEN Edited by Mario Campa, Mauro Bendinelli, and Herman Friedman PULMONARY INFECTIONS AND IMMUNITY Edited by Herman Chmel, Mauro Bendinelli, and Herman Friedman RAPID DETECTION OF INFECTIOUS AGENTS Edited by Steven Specter, Mauro Bendinelli, and Herman Friedman RICKETTSIAL INFECTION AND IMMUNITY Edited by Burt Anderson, Herman Friedman, and Mauro Bendinelli A Continuation Order Plan is available for this series. A continuation order will bring delivery of' each new volume immediately upon publication. Volumes are billed only upon actual shipment. For further information please contact the publisher. Opportunistic Intracellular Bacteria and Immunity Edited by Lois J. Paradise and Herman Friedman University of South Florida College of Medicine Tampa, Florida and Mauro Bendinelli University of Pisa Pisa, Italy Kluwer Academic Press New York / Boston / Dordrecht / London / Moscow eBook ISBN: 0-306-46809-3 Print ISBN: 0-306-45894-2 ©2002 Kluwer Academic Publishers New York, Boston, Dordrecht, London, Moscow All rights reserved No part of this eBook may be reproduced or transmitted in any form or by any means, electronic, mechanical, recording, or otherwise, without written consent from the Publisher Created in the United States of America Visit Kluwer Online at: http://www.kluweronline.com and Kluwer's eBookstore at: http://www.ebooks.kluweronline.com Contributors LINDA B. ADAMS • G. W. Long Hansen’s Research Center, Laboratory Research Branch, Louisiana State University, Baton Rouge, Louisiana 70803 BURT E. ANDERSON • Department of Medical Microbiology and Immu- nology, University of South Florida, College ofMedicine, Tampa, Florida 33612 CYNTHIA L. BALDWIN • Department of Veterinary and Animal Sciences, Paige Laboratory, University of Massachusetts, Amherst, Massachusetts 01003 ANDREW W. O. BURGESS • Department of Medical Microbiology and Immunology, University of South Florida, College of Medicine, Tampa, Florida 33612 GERALD I. BYRNE • Department of Medical Microbiology and Immunol- ogy, University of Wisconsin Medical School, Madison, Wisconsin 53706 FRANK M. COLLINS • Laboratory of Mycobacteria, CBER, FDA, Bethesda, Maryland 20852 PATRICIA A. DARRAH • Department of Microbiology and Immunol- ogy, Temple University School of Medicine, Philadelphia, Pennsylvania 19140 ROLIEN DE JONG • Department of Immunohematology and Blood Bank, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands v vi CONTRIBUTORS RENÉ R. P. DE VRIES • Department of Immunohematology and Blood Bank,LeidenUniversityMedicalCenter,2333ZALeiden,TheNetherlands JONS.FRIEDLAND • DepartmentofInfectiousDiseases,ImperialCollege, Hammersmith Hospital, London, W12ONN, England HERMANFRIEDMAN • DepartmentofMedicalMicrobiologyandImmu- nology, University ofSouth Florida, College ofMedicine, Tampa, Florida 33612 RAFAEL GARDUNO • Department of Microbiology and Immunology, Dalhousie University,Halifax,Nova Scotia B3H 3H7, Canada DAVID L. HAHN • Arcand Park Clinic, Dean Medical Center, Madison, Wisconsin 53705 ROGELIO HERNANDEZ-PANDO • Department of Pathology, Instituto Nacional de la Nutricion, Salvador Zubrian, Delegacion Tlalpan, 1400 MexicoDF M. B. HEVIN • Unité d’Immunophysiologie Cellulaire, Institut Pasteur, 75724 Paris-Cedex 15,France HERBERT HOF • Institute ofMedical Microbiology and Hygiene, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Manheim D-68165, Germany PAUL S. HOFFMAN • Departments of Microbiology, Immunology, and Medicine, Division ofInfectious Diseases, Dalhousie University, Halifax, Nova Scotia B3H 3H7, Canada MARYK. HONDALUS • Howard Hughes Medical Research Institute, Al- bert EinsteinCollegeofMedicine, Bronx, New York 1046l DAVIDJOHNSON • InfectiousDiseases Section,DepartmentofVeterinary Affairs Medical Center,Bay Pines, Florida 33744 MURATV. KALAYOGLU • DepartmentofMedicalMicrobiologyandIm- munology, University of Wisconsin Medical School, Madison, Wisconsin 53706 THOMAS W. KLEIN • Department ofMedical Microbiology and Immu- nology, University ofSouth Florida, College ofMedicine, Tampa, Florida 33612 JAMESL.KRAHENBUHL • G.W.LongHansen’sResearchCenter,Labo- ratory Research Branch, Louisiana State University, Baton Rouge, Louisiana 70803 CONTRIBUTORS vii M. LEBASTARD • Unité d’Immunophysiologie Cellulaire, InstitutPasteur, 75724 Paris-Cedex 15,France DANIELLE MALO • Departments of Medicine and Human Genetics, McGillUniversity,and Centre for the Study ofHost Resistance,Montreal General Hospital, Montreal, Quebec H3G 1A4,Canada G. MILON • United’Immunophysiologie Cellulaire, InstitutPasteur, 75724 Paris-Cedex 15,France DAVID M. MOSSER • Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140 CHARLES NAUCIEL • Faculté de Médecine de Paris-Ouest, Université Paris 5, 92380 Garches, France CATHERINE NEWTON • Department ofMedical Microbiology and Im- munology, University of South Florida, College of Medicine, Tampa, Florida33612 PETER H. NIBBERING • Department ofInfectious Diseases, Leiden Uni- versityMedical Center, 2333 ZA Leiden, The Netherlands TOM H. M. OTTENHOFF • Department of Immunohematology and Blood Bank, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands LOISJ. PARADISE • Department ofMedical Microbiology and Immunol- ogy, University of South Florida, College of Medicine, Tampa, Florida 33612 SALMAN T. QURESHI • Departments ofMedicine andHuman Genetics, McGill University, andCentre forthe Study ofHost Resistance, Montreal General Hospital, Montreal, Quebec H3G 1A4,Canada GRAHAMA. W. ROOK • Department ofBacteriology, University College LondonMedical School, London, W 1 P 6DB, England R. MARTIN ROOP II • Department of Microbiology and Immunology, Louisiana State University Medical Center, Shreveport, Louisiana 71130- 3939 JULIUSSCHACHTER • DepartmentofLaboratoryMedicine,Universityof California, San Francisco, San Francisco,California 94110 EMILSKAMENE • DepartmentsofMedicineandHumanGenetics,McGill University,and Centre forthe StudyofHost Resistance,Montreal General Hospital, Montreal, Quebec H3G 1A4,Canada viii CONTRIBUTORS ERIC SPIERINGS • Department of Immunohematology and Blood Bank, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands YOSHIMASA YAMAMOTO • Department of Medical Microbiology and Immunology, University of South Florida, College of Medicine, Tampa, Florida 33612 Preface to the Series Themechanismsofdiseaseproductionbyinfectious agents arepresentlythefocus of an unprecedented flowering of studies. The field has undoubtedly received impetus from the considerable advances recently made in the understanding of the structure, biochemistry, and biology of viruses, bacteria, fungi, and other parasites. Another contributing factor is our improved knowledge of immune responsesand otheradaptiveor constitutive mechanisms bywhichhostsreact to infection. Furthermore, recombinant DNA technology, monoclonal antibodies, and othernewer methodologies have provided the technical tools for examining questions previously considered too complex tobe successfullytackled.Themost important incentiveof all isprobably the regenerated ideathatinfection might be theinitiating event inmanyclinical entities presently classifiedasidiopathic orof uncertain origin. Infectious pathogenesis research holds greatpromise. As moreinformationis uncovered,itis becoming increasingly apparent that our present knowledge ofthe pathogenic potential of infectious agents is often limited to the most noticeable effects,which sometimes represent only the tip ofthe iceberg. For example, it is nowwell appreciated that pathologic processes caused by infectious agents may emerge clinically after an incubation of decades and may result from genetic, immunologic, and other indirect routes more than from the infecting agent in itself.Thus,thereisageneral expectation that continued investigationwillleadto the isolation ofnew agentsofinfection,theidentification of hitherto unsuspected etiologic correlations, and, eventually, more effectiveapproaches to prevention and therapy. Studies on the mechanisms ofdiseasecausedby infectious agents demanda breadthofunderstandingacrossmanyspecializedareas,aswellasmuch coopera- ix